GGrantIndex
Sort

64,565 grants matching drug discovery

Mitogenic and Oncogenic Regulation of ERK/RSK Signaling

$739,895
John Blenis · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA

Mitogenic and Oncogenic Regulation of ERK/RSK Signaling

$739,895
John Blenis · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA

Development of an Advanced In-Vitro Model for Angiogenesis Research and Drug Test

$739,884
Thomas Neumann · Nortis, Inc. · R44 · FY2015 · HL

Regulation of Candida albicans Pathogenesis by Protein Kinase and Transcription Factor Networks

$739,862
Damian J Krysan · University Of Iowa · R01 · FY2025 · AI

Development and Regulation of Emotion in Primates

$739,797
Ned H Kalin · University Of Wisconsin-Madison · R01 · FY2020 · MH

PAASPort: A web-based tool for nonclinical research quality assessment and risk of bias management to advance development of innovative medications

$739,750
Daniel R Deaver · Paasp Us, Llc · R44 · FY2020 · DA

Regulatory landscape of the human genome: comparative and evolutionary analysis.

$739,667
Ivan Ovcharenko · National Library Of Medicine · ZIA · FY2013 · LM

In silico Safety Pharmacology

$739,652
Colleen E Clancy · University Of California At Davis · R01 · FY2016 · HL

Repurposing Gram-positive Antibiotics for Gram-Negative Bacteria using Antibiotic Adjuvants

$739,601
Christian C Melander · University Of Notre Dame · R01 · FY2023 · AI

Developmental and Translational Pharmacology of Pediatric Antimicrobial Therapy

$739,569
Edmund Vincent Capparelli · University Of California, San Diego · U54 · FY2012 · HD

Pain drugs based on nicotinic receptor subtype antagonists

$739,558
Kelvin W Gee · University Of California-Irvine · R01 · FY2019 · DA

Small molecules for perturbing iron homeostasis in bacterial biofilms

$739,544
Mario Rivera · Louisiana State Univ A&M Col Baton Rouge · R01 · FY2025 · AI

Using bile salt metabolism to modulate CDI prophylaxis

$739,487
Ernesto V Abel-Santos · University Of Nevada Las Vegas · R01 · FY2024 · AI

Simplifying encoding of bioassays to accelerate translational drug discovery

$739,439
Barry A Bunin · Collaborative Drug Discovery, Inc. · R44 · FY2016 · TR

Chemistry principles applied to the development of new catalytic C-H bond functionalization methods for amine and heterocycle preparation and to the design, synthesis and use of new enzyme inhibitors

$739,409
Jonathan A. Ellman · Yale University · R35 · FY2019 · GM

Chemistry principles applied to the development of new catalytic C-H bond functionalization methods for amine and heterocycle preparation and to the design, synthesis and use of new enzyme inhibitors

$739,409
Jonathan A. Ellman · Yale University · R35 · FY2021 · GM

Chemistry principles applied to the development of new catalytic C-H bond functionalization methods for amine and heterocycle preparation and to the design, synthesis and use of new enzyme inhibitors

$739,409
Jonathan A. Ellman · Yale University · R35 · FY2018 · GM

Chemistry principles applied to the development of new catalytic C-H bond functionalization methods for amine and heterocycle preparation and to the design, synthesis and use of new enzyme inhibitors

$739,409
Jonathan A. Ellman · Yale University · R35 · FY2020 · GM

Development of linkage-specific ubiquitin binding elements

$739,313
James Strickler · Lifesensors, Inc. · R44 · FY2015 · CA

Relationships between APP and Mitochondria

$739,197
Heather M. Wilkins · University Of Kansas Medical Center · R01 · FY2024 · AG

Relationships between APP and Mitochondria

$739,197
Heather M. Wilkins · University Of Kansas Medical Center · R01 · FY2023 · AG

CAREER: Synthesis and Properties of Group IV Colloidal Quantum Wells

$739,133
Matthew G Panthani · Iowa State University · · FY2019 · MPS

Imaging of Neuropsychiatric Disorders with Developmental and Genetic Mechanisms

$739,002
Karen Faith Berman · National Institute Of Mental Health · ZIA · FY2016 · MH

Identification of GP38 and NP antibodies and their protective mechanisms against CCHFV

$738,880
Scott Dusan Pegan · University Of California Riverside · R01 · FY2025 · AI

Synthesis and Study of Natural and Non-natural Antiproliferative Agents

$738,832
Andrew G Myers · Harvard University · R01 · FY2016 · CA